Cefromin-SB 1.5 GM combines Cefoperazone and Sulbactam, offering potent antibacterial activity against severe infections. Cefoperazone, a third-generation cephalosporin, targets a wide range of gram-positive and gram-negative bacteria. Sulbactam inhibits beta-lactamase enzymes, enhancing Cefoperazone's effectiveness against resistant strains. Administered intravenously, Cefromin-SB 1.5 GM is crucial in hospital settings for treating complex infections. It provides robust therapy, addressing challenging bacterial infections and supporting positive patient outcomes in critical care scenarios.Available in PCD Franchise for injectable range and third party manufacturing.